Formulary Search Results for: TOLVAPTAN
6.5.2 Posterior pituitary hormones and antagonists - View Category
Total Formulary
TOLVAPTAN (JINARC) (tablets)
Restrictions:
Restricted to specialist use to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease.
Prescribing Notes:
Prescribing and associated monitoring of this medicine is to be carried out within the acute sector.
Use of tolvaptan for the treatment of SIADH is not recommended for use in NHSScotland by the SMC and is non-Formulary.